Indian Journal of Critical Care Medicine

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  28 (2024)
Volume  27 (2023)
Volume  26 (2022)
Volume  25 (2021)
Volume  24 (2020)
Volume  23 (2019)
Volume  22 (2018)
Volume  21 (2017)
Volume  20 (2016)
Volume  19 (2015)
Volume  18 (2014)
Volume  17 (2013)
Volume  16 (2012)
Volume  15 (2011)
Volume  14 (2010)
Volume  13 (2009)
Volume  12 (2008)
Volume  11 (2007)
Volume  10 (2006)
Volume  9 (2005)
Volume  8 (2004)
Related articles

VOLUME 27 , ISSUE 6 ( June, 2023 ) > List of Articles

Original Article

Extracorporeal Membrane Oxygenation for Severe COVID-19 in Indian Scenario: A Single Center Retrospective Study

Sulakshana Sulakshana, Dipanjan Chatterjee, Arpan Chakraborty

Keywords : Acute respiratory distress syndrome, COVID-19, Extracorporeal membrane oxygenation

Citation Information : Sulakshana S, Chatterjee D, Chakraborty A. Extracorporeal Membrane Oxygenation for Severe COVID-19 in Indian Scenario: A Single Center Retrospective Study. Indian J Crit Care Med 2023; 27 (6):381-385.

DOI: 10.5005/jp-journals-10071-24469

License: CC BY-NC 4.0

Published Online: 31-05-2023

Copyright Statement:  Copyright © 2023; The Author(s).


Abstract

Background: Initial reports from Wuhan (China) suggested poor outcomes for severe COVID-19 patients treated with Extracorporeal Membrane Oxygenation (ECMO). Extracorporeal Life Support Organization (ELSO) interim 2019 guidelines also recommended using ECMO only when all conventional therapies are exhausted. However, later studies showed that delayed ECMO initiation may lead to longer ECMO runs, offsetting any benefit from resource conservation by delaying the initiation. Hence, this study was intended to analyze the sociodemographic characteristics, type of ECMO, and complications of its outcome in the Indian scenario. Materials and methods: Demographic and patient clinical outcome data of all the patients of severe ARDS due to COVID-19 being treated with ECMO from 1st June 2020 to 31st May 2021 at Medica Super-specialty Hospital (Kolkata, India), were retrospectively compiled and analyzed. Results: Total number of patients treated was 79 with 10% female representation. The mean age was 43 ± 3.2 years and the mean body mass index 37 ± 4.3. Fifty percent of the patient survived. The mean duration of the ECMO run was 17 ± 5.2 days. Sepsis (65%) was the commonest complication observed followed by acute kidney injury (39%). Conclusion: This study provides significant insight into the outcomes of patients of COVID-19 treated by ECMO in the Indian scenario. Mortality rates of COVID-19 patients on ECMO were comparable to the non-COVID-19 patients, although the ECMO run time was relatively longer. Our study concluded that ECMO should be considered as a treatment option in appropriate COVID-19 cases. However, if the capacity diminishes in a pandemic situation, ECMO consideration should be based on more stringent criteria.

HTML PDF Share
  1. Badulak J, Antonini MV, Stead CM, Shekerdemian L, Raman L, Paden ML, et al. ELSO COVID-19 Working Group Members. Extracorporeal Membrane Oxygenation for COVID-19: Updated 2021 Guidelines from the Extracorporeal Life Support Organization. ASAIO J 2021;67(5):485–495. DOI: 10.1097/MAT.0000000000001422.
  2. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395(10223):497–506. DOI: 10.1016/S0140-6736(20)30183-5.
  3. Bhatraju PK, Ghassemieh BJ, Nichols M, Kim R, Jerome KR, Nalla AK, et al. Covid-19 in critically ill patients in the Seattle region—case series. N Engl J Med 2020;382(21):2012–2022. DOI: 10.1056/NEJMoa2004500.
  4. Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323(20):2052–2059. DOI: 10.1001/jama.2020.6775.
  5. Potere N, Valeriani E, Candeloro M, Tana M, Porreca E, Abbate A, et al. Acute complications and mortality in hospitalized patients with coronavirus disease 2019: A systematic review and meta-analysis. Crit Care 2020;24(1):389. DOI: 10.1186/s13054-020-03022-1.
  6. Shekar K, Badulak J, Peek G, Boeken U, Dalton HJ, Arora L, et al. ELSO Guideline Working Group. Extracorporeal Life Support Organization Coronavirus Disease 2019 Interim Guidelines: A Consensus Document from an International Group of Interdisciplinary Extracorporeal Membrane Oxygenation Providers. ASAIO J 2020;66(7):707–721. DOI: 10.1097/MAT.0000000000001193.
  7. Paolone S. Extracorporeal Membrane Oxygenation (ECMO) for Lung Injury in Severe Acute Respiratory Distress Syndrome (ARDS): Review of the Literature. Clin Nurs Res 2017;26:747–762. DOI: 10.1177/1054773816677808.
  8. Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single centered, retrospective, observational study. Lancet Respir Med 2020;8(5):475–481. DOI: 10.1016/S2213-2600(20)30079-5.
  9. Henry BM. COVID-19, ECMO, and lymphopenia: a word of caution. Lancet Respir Med 2020;8(4):e24. DOI: 10.1016/S2213-2600(20)30119-3.
  10. Černý D, Doležal T. Allocation of scarce resources in a pandemic. Cas Lek Cesk 2021;160(2–3):47–51. PMID: 34134491.
  11. Alshahrani MS, Sindi A, Alshamsi F, Al-Omari A, El Tahan M, Alahmadi B, et al. Extracorporeal membrane oxygenation for severe Middle East respiratory syndrome coronavirus. Ann Intensive Care 2018;8(1):3. DOI: 10.1186/s13613-017-0350-x.
  12. Cho HJ, Heinsar S, Jeong IS, Shekar K, Bassi GLi, Jung JS, et al. ECMO use in COVID-19: lessons from past respiratory virus outbreaks—a narrative review. Crit Care 2020;24(1):301. DOI: 10.1186/s13054-020-02979-3.
  13. Ramanathan K, Antognini D, Combes A, Paden M, Zakhary B, Ogino M, et al. Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases. Lancet Respir Med 2020;8(5):518–526. DOI: 10.1016/S2213-2600(20)30121-1.
  14. Smith NJ, Park S, Zundel MT, Dong H, Szabo A, Cain MT, et al. Extracorporeal membrane oxygenation for COVID-19: An evolving experience through multiple waves. Artif Organs 2022;46(11): 2257–2265. DOI: 10.1111/aor.14381.
  15. Force ADT, Ranieri V, Rubenfeld G, Thompson B, Ferguson N, Caldwell E, et al. Acute respiratory distress syndrome. JAMA 2012;307(23): 2526–2533. DOI: 10.1001/jama.2012.5669.
  16. Levy MM, Evans LE, Rhodes A. The surviving sepsis campaign bundle: 2018 update. Intensive Care Med 2018;44(6):925–928. DOI: 10.1007/s00134-018-5085-0.
  17. Akhtar W, Olusanya O, Baladia MM, Young H, Shah S. SARS-CoV-2 and ECMO: early results and experience. Indian J Thorac Cardiovasc Surg 2021;37(1):53–60. DOI: 10.1007/s12055-020-01084-y.
  18. Schmidt M, Hajage D, Lebreton G, Monsel A, Voiriot G, Levy D, et al. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: A retrospective cohort study. Lancet Respir Med 2020;8(11):1121–1131. DOI: 10.1016/S2213-2600(20)30328-3.
  19. Mustafa AK, Alexander PJ, Joshi DJ, Tabachnick DR, Cross CA, Pappas PS, et al. Extracorporeal Membrane Oxygenation for Patients With COVID-19 in Severe Respiratory Failure. JAMA Surg 2020;155(10): 990–992. DOI: 10.1001/jamasurg.2020.3950.
  20. Saeed O, Tatooles AJ, Farooq M, Schwartz G, Pham DT, Mustafa AK, et al. Characteristics and outcomes of patients with COVID-19 supported by extracorporeal membrane oxygenation: A retrospective multicenter study. J Thorac Cardiovasc Surg 2022;163(6):2107–2116;e6. DOI: 10.1016/j.jtcvs.2021.04.089.
  21. Taslem Mourosi J, Anwar S, Hosen MJ. The sex and gender dimensions of COVID-19: A narrative review of the potential underlying factors. Infect Genet Evol 2022;103:105338. DOI: 10.1016/j.meegid.2022.105338.
  22. Sudhakar M, Winfred SB, Meiyazhagan G, Venkatachalam DP. Mechanisms contributing to adverse outcomes of COVID-19 in obesity. Mol Cell Biochem 2022;477(4):1155–1193. DOI: 10.1007/s11010-022-04356-w.
  23. Muskiet FAJ, Carrera-Bastos P, Pruimboom L, Lucia A, Furman D. Obesity and Leptin Resistance in the Regulation of the Type I Interferon Early Response and the Increased Risk for Severe COVID-19. Nutrients 2022;14(7):1388. DOI: 10.3390/nu14071388.
  24. Kohne JG, MacLaren G, Cagino L, Boonstra PS, Brodie D, Barbaro RP. Tracheostomy Practices and Outcomes in Patients With COVID-19 Supported by Extracorporeal Membrane Oxygenation: An Analysis of the Extracorporeal Life Support Organization Registry. Crit Care Med 2022;50(9):1360–1370. DOI: 10.1097/CCM.0000000000005579.
  25. Ling RR, Ramanathan K, Sim JJL, Wong SN, Chen Y, Amin F, et al. Evolving outcomes of extracorporeal membrane oxygenation during the first 2 years of the COVID-19 pandemic: A systematic review and meta-analysis. Crit Care 2022;26(1):147. DOI: 10.1186/s13054-022-04011-2.
  26. Akil A, Ziegeler S, Reichelt J, Rehers S, Abdalla O, Semik M, et al. Combined Use of CytoSorb and ECMO in Patients with Severe Pneumogenic Sepsis. Thorac Cardiovasc Surg 2021;69(3):246–251. DOI: 10.1055/s-0040-1708479.
  27. Kogelmann K, Hübner T, Schwameis F, Drüner M, Scheller M, Jarczak D. First Evaluation of a New Dynamic Scoring System Intended to Support Prescription of Adjuvant CytoSorb Hemoadsorption Therapy in Patients with Septic Shock. J Clin Med 2021;10(13):2939. DOI: 10.3390/jcm10132939.
  28. Ruiz-Rodríguez JC, Chiscano-Camón L, Ruiz-Sanmartin A, Palmada C, Paola Plata-Menchaca E, Franco-Jarava C, et al. Cytokine Hemoadsorption as Rescue Therapy for Critically Ill Patients With SARS-CoV-2 Pneumonia With Severe Respiratory Failure and Hypercytokinemia. Front Med (Lausanne) 2022;8:77903830. DOI: 10.3389/fmed.2021.779038.
  29. Sulakshana S, Nayak SS, Perumal S, Das BP. Heparin-Induced Thrombocytopenia in COVID-19: A Systematic Review. Anesth Essays Res 2021;15(4):341–347. DOI: 10.4103/aer.aer_151_21.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.